| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Endonovo Therapeutics, Inc. (ENDV) has 0 insiders with recent SEC Form 4 filings, including 183 buys and 0 sells. ENDV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 18, 2019 | Mann Michael Scott | President | Buy | 10,000 | $0.03 | $275.80 | - | |
| Jan 16, 2019 | Collier Alan Brian | CEO | Buy | 161,500 | $0.03 | $5,056.30 | - | |
| Jan 15, 2019 | Mann Michael Scott | President | Buy | 21,000 | $0.02 | $497.60 | - | |
| Jan 14, 2019 | Collier Alan Brian | CEO | Buy | 45,000 | $0.03 | $1,493.50 | - | |
| Jan 9, 2019 | Mann Michael Scott | President | Buy | 8,200 | $0.02 | $153.89 | - | |
| Jan 9, 2019 | Collier Alan Brian | CEO | Buy | 45,000 | $0.02 | $852.00 | - | |
| Jan 2, 2019 | Mann Michael Scott | President | Buy | 41,100 | $0.02 | $772.19 | - | |
| Dec 26, 2018 | Mann Michael Scott | President | Buy | 30,500 | $0.02 | $604.79 | - | |
| Dec 24, 2018 | Mann Michael Scott | President | Buy | 83,199 | $0.02 | $1,739.44 | - | |
| Dec 21, 2018 | Mann Michael Scott | President | Buy | 138,000 | $0.02 | $2,542.70 | - |